We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
-36.00 | -0.34% | 10,424.00 | 10,424.00 | 10,428.00 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
10,482.00 | 10,414.00 | 10,450.00 | 183,251 | 14:25:22 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 45.81B | 5.96B | 3.8411 | 27.22 | 162.16B |
Date | Time | Source | Headline |
---|---|---|---|
24/12/2024 | 08:20 | ALNC | AstraZeneca and Daiichi withdraw EU application for lung cancer drug |
24/12/2024 | 07:00 | UK RNS | AstraZeneca PLC Dato-DXd NSQ NSCLC application withdrawn in EU |
23/12/2024 | 10:13 | ALNC | AstraZeneca receives EU approval for Tagrisso lung cancer treatment |
23/12/2024 | 07:00 | UK RNS | AstraZeneca PLC Tagrisso approved in EU based on LAURA trial |
18/12/2024 | 12:44 | ALNC | PRESS: AstraZeneca sees sales slump in China after arrest of exec - FT |
16/12/2024 | 07:00 | UK RNS | AstraZeneca PLC Directorate Change |
11/12/2024 | 19:40 | ALNC | IN BRIEF: Merck and AstraZeneca unveil long-term Lynparza results |
09/12/2024 | 09:09 | ALNC | AstraZeneca, Daiichi Sankyo hail US breakthrough therapy designation |
05/12/2024 | 09:46 | ALNC | AstraZeneca touts US FDA approval for small cell lung cancer treatment |
05/12/2024 | 07:00 | UK RNS | AstraZeneca PLC Imfinzi approved in US for limited-stage SCLC |
1 Year Astrazeneca Chart |
Intraday Astrazeneca Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions